Meredith Manning, Chief Commercial Officer at SOLENO THERAPEUTICS INC (SLNO), sold 15,044 shares at $30.04 ($458K) on 2026-03-27, disclosed to the SEC on 2026-03-31.
Open-market sale of $458k SLNO by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.04 | 4,864 | $146K | 31.9% |
| 2 | $30.04 | 4,864 | $146K | 31.9% |
| 3 | $31.04 | 2,100 | $65K | 14.2% |
| 4 | $31.04 | 2,100 | $65K | 14.2% |
| 5 | $31.72 | 558 | $18K | 3.9% |
| 6 | $31.72 | 558 |
| $18K |
| 3.9% |
| Total | $30.44 avg | 15,044 | $458K | 100% |